Showing results (91-100 of 349) with videos related to

Sort By:
Pageof 35
The European Respiratory Journal|August 25, 2018
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthmaEugene R Bleecker, Michael E Wechsler, J Mark FitzGerald, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trialCourtney Crim, Sally Stone, Valerie Millar, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2012
IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonistRebecca E Slager, Babatunde A Otulana, Gregory A Hawkins, et al.
American Journal of Respiratory Cell and Molecular Biology|December 9, 2008
Glucocorticoid- and protein kinase A-dependent transcriptome regulation in airway smooth muscleAnna M Misior, Deepak A Deshpande, Matthew J Loza, et al.
The Journal of Allergy and Clinical Immunology|February 20, 2021
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatmentWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
BMC Pulmonary Medicine|May 1, 2016
Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trialJames F Donohue, Robert Wise, William W Busse, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 6, 2004
Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthmaChantal M Dolan, Kyle E Fraher, Eugene R Bleecker, et al.
Respiratory Medicine|February 21, 2012
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trialEric D Bateman, Eugene R Bleecker, Jan Lötvall, et al.
The Lancet. Respiratory Medicine|September 12, 2014
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a studyChristopher E Brightling, Eugene R Bleecker, Reynold A Panettieri, et al.
Thorax|November 21, 2013
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF aloneEric D Bateman, Paul M O'Byrne, William W Busse, et al.
Pageof 35